Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1725 of 2873 entries
View as:

A Pilot Study of Glutamine PET Imaging of Head and Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05322135 Org: User:
Start: 09/14/22 End: 03/07/25 Due: 03/07/26

Natural History of Lung Nodules Seen on CT Scans From Participants at High-Risk of Developing Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01540552 Org: User:
Start: 02/29/12 End: 01/31/13 Due: 01/31/14

Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00047710 Org: User:
Start: 09/30/02 End: 07/31/06 Due: 07/31/07

18F-FSPG PET/CT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06549413 Org: User:
Start: 08/23/23 End: 12/31/27 Due: 12/31/28

Gleevec/Low-Dose Ara-C Study for Elderly Patients With AML and Myelodysplastic Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT00451997 Org: User:
Start: 03/31/04 End: 04/30/07 Due: 04/30/08

Phase I Trial of MT-0169 in CD38+ Acute Leukemia With Relapsed/Refractory or Measurable Residual Disease

Phase: N/A Priority: Normal
NCT ID: NCT06522373 Org: User:
Start: 10/21/24 End: 10/21/24 Due: 10/21/25

Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC

Phase: N/A Priority: Normal
NCT ID: NCT02593175 Org: User:
Start: 08/26/16 End: 04/03/25 Due: 04/03/26

AMG 208 Tumor Microenvironment in Metastatic Castration Resistant Prostate Cancer (mCRPC)

Phase: N/A Priority: Normal
NCT ID: NCT02420587 Org: User:
Start: 10/31/14 End: - Due: -

Acupuncture for Prevention of Radiation-Induced Xerostomia

Phase: N/A Priority: Normal
NCT ID: NCT00430378 Org: User:
Start: 01/31/07 End: 05/27/21 Due: 05/27/22

Dyadic Yoga Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers: The Testing of a Mobile Application Delivery

Phase: N/A Priority: Normal
NCT ID: NCT06919874 Org: User:
Start: 09/01/25 End: 12/31/28 Due: 12/31/29

ARID1A and/or KDM6A Mutation and CXCL13 Expression

Phase: N/A Priority: Normal
NCT ID: NCT04953104 Org: User:
Start: 09/21/21 End: 12/31/26 Due: 12/31/27

A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)

Phase: N/A Priority: Normal
NCT ID: NCT06561074 Org: User:
Start: 06/30/25 End: 12/31/31 Due: 12/31/32

Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT05879120 Org: User:
Start: 07/30/24 End: 10/02/24 Due: 10/02/25

Combined Colon and Endometrial Cancer Screening in Women With HNPCC

Phase: N/A Priority: Normal
NCT ID: NCT00510796 Org: User:
Start: 03/31/02 End: 12/31/15 Due: 12/31/16

Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigating Radiation-response and Toxicity

Phase: N/A Priority: Normal
NCT ID: NCT06909201 Org: User:
Start: 09/01/25 End: 09/01/30 Due: 09/01/31

A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS

Phase: N/A Priority: Normal
NCT ID: NCT00656448 Org: User:
Start: 03/31/08 End: 06/30/13 Due: 06/30/14

IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01409174 Org: User:
Start: 02/28/13 End: 05/31/16 Due: 05/31/17

An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04978675 Org: User:
Start: 08/04/21 End: 06/04/24 Due: 06/04/25

TPI 287 in Patients With Recurrent Glioblastoma Multiforme

Phase: N/A Priority: Normal
NCT ID: NCT01113463 Org: User:
Start: 04/30/10 End: 12/31/12 Due: 12/31/13

Extraperitoneal Lymph Node Dissection in Patients With Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00500435 Org: User:
Start: 10/31/03 End: 05/31/11 Due: 05/31/12

Lymphoscintigraphy in Patients With Vaginal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00528034 Org: User:
Start: 09/30/02 End: 05/31/08 Due: 05/31/09

Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01036087 Org: User:
Start: 11/30/10 End: 08/09/22 Due: 08/09/23

Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain

Phase: N/A Priority: Normal
NCT ID: NCT02459964 Org: User:
Start: 09/14/15 End: 06/21/20 Due: 06/21/21

Quantitative Diffusion and Fat Imaging of the Spine

Phase: N/A Priority: Normal
NCT ID: NCT00498277 Org: User:
Start: 08/31/04 End: 07/31/09 Due: 07/31/10

Colorectal Cancer (CRC) Surveillance Tool: Cognitive and Pilot Testing

Phase: N/A Priority: Normal
NCT ID: NCT03180411 Org: User:
Start: 02/14/17 End: 11/30/22 Due: 11/30/23